Market Tracker

08/28 6:01pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

536.70
Delayed Data
As of Aug 28
 -1.30 / -0.24%
Today’s Change
320.06
Today|||52-Week Range
605.93
+30.82%
Year-to-Date

Today’s Trading

Previous close538.00
Today’s open530.39
Day’s range530.16 - 543.12
Volume507,771
Average volume (3 months)752,509
Market cap$55.8B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+21.79%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio135.1
Price/Sales16.50
Price/Book21.68

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.04+1.40%
ALNYAlnylam Pharmaceutic...+4.17+3.98%
ISISIsis Pharmaceuticals...-0.02-0.04%
ICLRICON PLC-0.76-0.97%
Data as of 4:03pm ET, 08/28/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$3.10
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts